Literature DB >> 9771776

MELAS: a new disease associated mitochondrial DNA mutation and evidence for further genetic heterogeneity.

M G Hanna1, I P Nelson, J A Morgan-Hughes, N W Wood.   

Abstract

OBJECTIVES: To define the molecular genetic basis of the MELAS phenotype in five patients without any known mutation of mitochondrial DNA.
METHODS: Systematic automated mitochondrial DNA sequencing of all mitochondrial transfer RNA and cytochrome c oxidase genes was undertaken in five patients who had the MELAS phenotype.
RESULTS: A novel heteroplasmic mitochondrial DNA mutation was identified in the transfer RNA gene for phenylalanine in one case (patient 3). This mutation was not detected in the patient's blood or in her mother's blood. No pathogenic mutations were identified in the other four patients.
CONCLUSIONS: This is the first point mutation in the transfer RNA gene for phenylalanine to be associated with MELAS. The absence of mutations in the remaining four patients suggests that there is further genetic heterogeneity associated with this mitochondrial phenotype.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9771776      PMCID: PMC2170312          DOI: 10.1136/jnnp.65.4.512

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  42 in total

1.  A new mitochondrial DNA mutation associated with progressive dementia and chorea: a clinical, pathological, and molecular genetic study.

Authors:  I Nelson; M G Hanna; N Alsanjari; F Scaravilli; J A Morgan-Hughes; A E Harding
Journal:  Ann Neurol       Date:  1995-03       Impact factor: 10.422

2.  Identification of a mutation in the mitochondrial tRNA(Cys) gene associated with mitochondrial encephalopathy.

Authors:  G Manfredi; E A Schon; E Bonilla; C T Moraes; S Shanske; S DiMauro
Journal:  Hum Mutat       Date:  1996       Impact factor: 4.878

3.  Presentation and clinical investigation of mitochondrial respiratory chain disease. A study of 51 patients.

Authors:  M J Jackson; J A Schaefer; M A Johnson; A A Morris; D M Turnbull; L A Bindoff
Journal:  Brain       Date:  1995-04       Impact factor: 13.501

4.  A mitochondrial tRNA(Leu)(UUR) mutation at 3,256 associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS).

Authors:  W Sato; K Hayasaka; Y Shoji; T Takahashi; G Takada; M Saito; O Fukawa; E Wachi
Journal:  Biochem Mol Biol Int       Date:  1994-08

5.  A MERRF/MELAS overlap syndrome associated with a new point mutation in the mitochondrial DNA tRNA(Lys) gene.

Authors:  M Zeviani; F Muntoni; N Savarese; G Serra; V Tiranti; F Carrara; C Mariotti; S DiDonato
Journal:  Eur J Hum Genet       Date:  1993       Impact factor: 4.246

6.  Familial poliodystrophy, mitochondrial myopathy, and lactate acidemia.

Authors:  Y Shapira; S D Cederbaum; P A Cancilla; D Nielsen; B M Lippe
Journal:  Neurology       Date:  1975-07       Impact factor: 9.910

7.  Mitochondrial DNA deletion in a patient with mitochondrial myopathy, lactic acidosis, and stroke-like episodes (MELAS) and Fanconi's syndrome.

Authors:  Y Campos; T Garcia-Silva; C R Barrionuevo; A Cabello; R Muley; J Arenas
Journal:  Pediatr Neurol       Date:  1995-07       Impact factor: 3.372

8.  The mitochondrial DNA transfer RNALeu(UUR) A-->G(3243) mutation. A clinical and genetic study.

Authors:  S R Hammans; M G Sweeney; M G Hanna; M Brockington; J A Morgan-Hughes; A E Harding
Journal:  Brain       Date:  1995-06       Impact factor: 13.501

9.  A novel point mutation in the mitochondrial tRNA(Ser(UCN)) gene detected in a family with MERRF/MELAS overlap syndrome.

Authors:  M Nakamura; S Nakano; Y Goto; M Ozawa; Y Nagahama; H Fukuyama; I Akiguchi; R Kaji; J Kimura
Journal:  Biochem Biophys Res Commun       Date:  1995-09-05       Impact factor: 3.575

10.  A new mutation associated with MELAS is located in a mitochondrial DNA polypeptide-coding gene.

Authors:  G Manfredi; E A Schon; C T Moraes; E Bonilla; G T Berry; J T Sladky; S DiMauro
Journal:  Neuromuscul Disord       Date:  1995-09       Impact factor: 4.296

View more
  12 in total

Review 1.  Mitochondrial threshold effects.

Authors:  Rodrigue Rossignol; Benjamin Faustin; Christophe Rocher; Monique Malgat; Jean-Pierre Mazat; Thierry Letellier
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

2.  Apparent diffusion coefficients of metabolites in patients with MELAS using diffusion-weighted MR spectroscopy.

Authors:  Z Liu; D Zheng; X Wang; J Zhang; S Xie; J Xiao; X Jiang
Journal:  AJNR Am J Neuroradiol       Date:  2011-02-24       Impact factor: 3.825

3.  The appearance of ADCs in the non-affected areas of the patients with MELAS.

Authors:  Zhenghua Liu; Xiwei Liu; Lihong Hui; Danhua Zhao; Xiaoying Wang; Sheng Xie; Jiangxi Xiao; Xuexiang Jiang
Journal:  Neuroradiology       Date:  2010-06-17       Impact factor: 2.804

Review 4.  Mitochondrial dysfunction in neurological disorders with epileptic phenotypes.

Authors:  Gábor Zsurka; Wolfram S Kunz
Journal:  J Bioenerg Biomembr       Date:  2010-12       Impact factor: 2.945

5.  Pathogenic mechanism of a human mitochondrial tRNAPhe mutation associated with myoclonic epilepsy with ragged red fibers syndrome.

Authors:  Jiqiang Ling; Hervé Roy; Daoming Qin; Mary Anne T Rubio; Juan D Alfonzo; Kurt Fredrick; Michael Ibba
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-18       Impact factor: 11.205

6.  Gitelman-Like Syndrome Caused by Pathogenic Variants in mtDNA.

Authors:  Daan Viering; Karl P Schlingmann; Marguerite Hureaux; Tom Nijenhuis; Andrew Mallett; Melanie M Y Chan; André van Beek; Albertien M van Eerde; Jean-Marie Coulibaly; Marion Vallet; Stéphane Decramer; Solenne Pelletier; Günter Klaus; Martin Kömhoff; Rolf Beetz; Chirag Patel; Mohan Shenoy; Eric J Steenbergen; Glenn Anderson; Ernie M H F Bongers; Carsten Bergmann; Daan Panneman; Richard J Rodenburg; Robert Kleta; Pascal Houillier; Martin Konrad; Rosa Vargas-Poussou; Nine V A M Knoers; Detlef Bockenhauer; Jeroen H F de Baaij
Journal:  J Am Soc Nephrol       Date:  2021-10-04       Impact factor: 10.121

7.  A new phenotype of mitochondrial disease characterized by familial late-onset predominant axial myopathy and encephalopathy.

Authors:  Yusuke Sakiyama; Yuji Okamoto; Itsuro Higuchi; Yukie Inamori; Yoko Sangatsuda; Kumiko Michizono; Osamu Watanabe; Hideyuki Hatakeyama; Yu-ichi Goto; Kimiyoshi Arimura; Hiroshi Takashima
Journal:  Acta Neuropathol       Date:  2011-03-22       Impact factor: 17.088

8.  Mitochondrial diabetes in children: seek and you will find it.

Authors:  Cristina Mazzaccara; Dario Iafusco; Rosario Liguori; Maddalena Ferrigno; Alfonso Galderisi; Domenico Vitale; Francesca Simonelli; Paolo Landolfo; Francesco Prisco; Mariorosario Masullo; Lucia Sacchetti
Journal:  PLoS One       Date:  2012-04-19       Impact factor: 3.240

9.  De novo mtDNA point mutations are common and have a low recurrence risk.

Authors:  Suzanne C E H Sallevelt; Christine E M de Die-Smulders; Alexandra T M Hendrickx; Debby M E I Hellebrekers; Irenaeus F M de Coo; Charlotte L Alston; Charlotte Knowles; Robert W Taylor; Robert McFarland; Hubert J M Smeets
Journal:  J Med Genet       Date:  2016-07-22       Impact factor: 6.318

10.  Significant Association Between Low Mitochondrial DNA Content in Peripheral Blood Leukocytes and Ischemic Stroke.

Authors:  Li-Ming Lien; Hung-Yi Chiou; Hsu-Ling Yeh; Shang-Yen Chiu; Jiann-Shing Jeng; Huey-Juan Lin; Chaur-Jong Hu; Fang-I Hsieh; Yau-Huei Wei
Journal:  J Am Heart Assoc       Date:  2017-11-18       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.